ARGS
Geode Capital Management’s Argos Therapeutics, Inc. ARGS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-114,999
| Closed | -$17K | – | 4152 |
|
|
2017
Q4 | $17K | Sell |
114,999
-14,047
| -11% | -$2.08K | ﹤0.01% | 4000 |
|
|
2017
Q3 | $23K | Hold |
129,046
| – | – | ﹤0.01% | 4010 |
|
|
2017
Q2 | $46K | Sell |
129,046
-28,661
| -18% | -$10.2K | ﹤0.01% | 3973 |
|
|
2017
Q1 | $71K | Buy |
157,707
+4,642
| +3% | +$2.09K | ﹤0.01% | 3891 |
|
|
2016
Q4 | $750K | Buy |
153,065
+4,835
| +3% | +$23.7K | ﹤0.01% | 3122 |
|
|
2016
Q3 | $736K | Buy |
148,230
+55,517
| +60% | +$276K | ﹤0.01% | 3094 |
|
|
2016
Q2 | $568K | Buy |
92,713
+43,862
| +90% | +$269K | ﹤0.01% | 3172 |
|
|
2016
Q1 | $312 | Buy |
48,851
+3,559
| +8% | +$23 | ﹤0.01% | 3454 |
|
|
2015
Q4 | $104K | Buy |
45,292
+122
| +0.3% | +$280 | ﹤0.01% | 3875 |
|
|
2015
Q3 | $219K | Buy |
45,170
+122
| +0.3% | +$591 | ﹤0.01% | 3648 |
|
|
2015
Q2 | $308K | Buy |
45,048
+61
| +0.1% | +$417 | ﹤0.01% | 3418 |
|
|
2015
Q1 | $400K | Buy |
44,987
+6,937
| +18% | +$61.7K | ﹤0.01% | 3288 |
|
|
2014
Q4 | $380K | Buy |
38,050
+183
| +0.5% | +$1.83K | ﹤0.01% | 3307 |
|
|
2014
Q3 | $380K | Buy |
37,867
+17,083
| +82% | +$171K | ﹤0.01% | 3283 |
|
|
2014
Q2 | $166K | Sell |
20,784
-2,864
| -12% | -$22.9K | ﹤0.01% | 3567 |
|
|
2014
Q1 | $236K | Buy |
+23,648
| New | +$236K | ﹤0.01% | 3449 |
|